BHRB(BHRB)
BHRB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $439M | $494M | $929M | $1.30B |
| Low | $439M | $494M | $928M | $1.29B |
| High | $439M | $494M | $929M | $1.30B |
| EBITDA Avg | $128M | $144M | $271M | $378M |
| Low | $128M | $144M | $271M | $378M |
| High | $128M | $144M | $271M | $379M |
| EBIT Avg | $114M | $129M | $242M | $337M |
| Low | $114M | $129M | $242M | $337M |
| High | $114M | $129M | $242M | $337M |
| Net Income Avg | $114M | $132M | $146M | $135M |
| Low | $111M | $131M | $146M | $135M |
| High | $117M | $133M | $146M | $135M |
| EPS Avg | $7.58 | $8.77 | $9.72 | $8.97 |
| Low | $7.37 | $8.69 | $9.71 | $8.96 |
| High | $7.78 | $8.85 | $9.73 | $8.98 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 2 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $121M | $122M | $121M | $123M | $124M | $125M |
| Low | $121M | $122M | $121M | $123M | $124M | $125M |
| High | $122M | $122M | $121M | $123M | $125M | $126M |
| EBITDA Avg | $35M | $36M | $35M | $36M | $36M | $37M |
| Low | $35M | $36M | $35M | $36M | $36M | $37M |
| High | $36M | $36M | $35M | $36M | $36M | $37M |
| EBIT Avg | $32M | $32M | $32M | $32M | $32M | $33M |
| Low | $32M | $32M | $31M | $32M | $32M | $33M |
| High | $32M | $32M | $32M | $32M | $32M | $33M |
| Net Income Avg | $31M | $32M | $32M | $33M | $34M | $34M |
| Low | $31M | $32M | $32M | $33M | $33M | $34M |
| High | $32M | $32M | $32M | $33M | $34M | $34M |
| EPS Avg | $2.05 | $2.09 | $2.13 | $2.18 | $2.22 | $2.24 |
| Low | $2.02 | $2.09 | $2.12 | $2.18 | $2.21 | $2.23 |
| High | $2.08 | $2.10 | $2.13 | $2.19 | $2.22 | $2.24 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |